These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38879606)

  • 21. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying Clinical and Genetic Characteristics of Spinal Muscular Atrophy Patients and Families in Saudi Arabia.
    Alghamdi A; AlDossary S; Abdulaziz Alabdulqader W; Amer F; Ali M; Almomen M; Alghamdi F
    Cureus; 2023 Oct; 15(10):e46452. PubMed ID: 37927698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consanguineous marriages in the United Arab Emirates.
    al-Gazali LI; Bener A; Abdulrazzaq YM; Micallef R; al-Khayat AI; Gaber T
    J Biosoc Sci; 1997 Oct; 29(4):491-7. PubMed ID: 9881148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Carrier Frequency of Two
    Davidson JE; Russell JS; Martinez NN; Mowat DR; Jones KJ; Kirk EP; Kariyawasam D; Farrar M; D'Silva A
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].
    Gong B; Zhang L; Hou YP; Hu HY; Li HC; Tan MY; Chen J; Yu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):670-2. PubMed ID: 24327144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a national population-based carrier-screening program on spinal muscular atrophy births.
    Aharoni S; Nevo Y; Orenstein N; Basel-Salmon L; Ben-Shachar S; Mussaffi H; Sagi-Dain L; Cohen R; Singer A
    Neuromuscul Disord; 2020 Dec; 30(12):970-974. PubMed ID: 33218846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier Screening and Diagnosis for Spinal Muscular Atrophy Using Droplet Digital PCR Versus MLPA: Analytical Validation and Early Test Outcome.
    Shekhawat DS; Didel S; Dixit SG; Singh P; Singh K
    Genet Test Mol Biomarkers; 2024 May; 28(5):207-212. PubMed ID: 38533877
    [No Abstract]   [Full Text] [Related]  

  • 31. Spinal Muscular Atrophy: Overview of Molecular Diagnostic Approaches.
    Prior TW; Nagan N
    Curr Protoc Hum Genet; 2016 Jan; 88():9.27.1-9.27.13. PubMed ID: 26724723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy.
    D'Amico A; Mercuri E; Tiziano FD; Bertini E
    Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
    Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
    Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.
    Sugarman EA; Nagan N; Zhu H; Akmaev VR; Zhou Z; Rohlfs EM; Flynn K; Hendrickson BC; Scholl T; Sirko-Osadsa DA; Allitto BA
    Eur J Hum Genet; 2012 Jan; 20(1):27-32. PubMed ID: 21811307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier Frequency of Spinal Muscular Atrophy in a Large-scale Korean Population.
    Park JE; Yun SA; Roh EY; Yoon JH; Shin S; Ki CS
    Ann Lab Med; 2020 Jul; 40(4):326-330. PubMed ID: 32067433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
    Paracha N; Hudson P; Mitchell S; Sutherland CS
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal muscular atrophy: from gene discovery to clinical trials.
    Nurputra DK; Lai PS; Harahap NI; Morikawa S; Yamamoto T; Nishimura N; Kubo Y; Takeuchi A; Saito T; Takeshima Y; Tohyama Y; Tay SK; Low PS; Saito K; Nishio H
    Ann Hum Genet; 2013 Sep; 77(5):435-63. PubMed ID: 23879295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia.
    Memish ZA; Saeedi MY
    Ann Saudi Med; 2011; 31(3):229-35. PubMed ID: 21623050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data Sources.
    Price TR; Hodgkinson V; Westbury G; Korngut L; Innes MA; Marshall CR; Nelson TN; Huang L; Parboosingh J; Mah JK
    Can J Neurol Sci; 2024 Jan; ():1-12. PubMed ID: 38178730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence.
    Hjartarson HT; Nathorst-Böös K; Sejersen T
    Drug Des Devel Ther; 2022; 16():1865-1883. PubMed ID: 35734367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.